Pharmaceutical Filtration Market to Hit USD 20.97 Billion by 2029 with 9.5% CAGR | MarketsandMarkets™

Browse in-depth TOC on "Pharmaceutical Filtration Market"

944 - Tables
60 - Figures
645 - Pages

Based on type, the pharmaceutical filtration market is segmented into sterile filtration and non-sterile filtration. The sterile filtration segment accounted for the largest share of the pharmaceutical filtration market. This can be owing to increasing demand for biologics drugs and rising research and development activities for development of advanced biopharmaceuticals.

Among technique segment, the pharmaceutical filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. The Microfiltration segment accounted for the largest share of the pharmaceutical filtration market. The large share of this segment can be owing to the increasing adoption of microfiltration technique for clarification, purification of cell broths, the separation of cell debris, and the separation of macromolecules.

Among scale of operation segment, the pharmaceutical filtration market is segmented into manufacturing-scale operations, pilot-scale operations, and R&D-scale operations. The manufacturing-scale operations segment accounted for the largest share of the pharmaceutical filtration market. The large share of this segment can be owing to the growth in biologics and biosimilar manufacturing. Additionally, increasing number of biopharmaceuticals receiving regulatory approvals for production and the launch of biosimilars in the market is propelling the growth of the segment in pharmaceutical filtration market.

Among application segment, the pharmaceutical filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. Final product processing segment is further categorized as active pharmaceutical ingredient filtration, protein purification, vaccine and antibody processing, formulation and filling solutions, viral clearance. Additionally, raw material filtration segment is divided as media buffer filtration, prefiltration, bioburden testing. In 2023, final product processing was the largest and fastest-growing application segment in the global pharmaceutical filtration market. The stringent regulatory mandates, the rapidly growing biopharmaceutical industry, and increased generics and biologics manufacturing are the key growth drivers for this application segment.

Based on region, the pharmaceutical filtration market is segmented by region into six key areas: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2023, North America led the market, followed by Europe in second place and the Asia Pacific in third. North America is expected to experience the highest growth rate during the forecast period. Factors driving this regional growth include the expansion of pharmaceutical R&D activities, rising demand for biopharmaceuticals, increasing fundings and investments in biopharmaceutical industries.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=209343847

Merck KGaA (Germany), Danaher Corporation (US), and Sartorius AG (Germany) holding the significant global market share and the global pharmaceutical filtration market is highly consolidated.

Merck KGaA (Germany)

Merck KGaA dominated the pharmaceutical filtration market in 2023. Merck KGaA is a leading life science company offering wide range of pharmaceutical filtration products. The company operates through three business segments such as Healthcare, Life Science, and Performance Material. The Process Solutions business unit comes under Life Science segment, sells products and services for the pharmaceutical production. The substantial contribution and continuous growth of this segment primarily owe to the powerful product portfolio, brand recognition, and heightened demand for bioprocessing technologies, including filtration products from bioprocessing business units, especially in the region of Asia Pacific and North America.

Danaher Corporation (US)

Danaher is one of the leading players in pharmaceutical filtration market. the company offers wide range of pharmaceutical filtration solutions such as membranes, syringe filters, vacuum devices, and large-molecular capsules. Thus, broad product portfolio and strong distribution network across the world, help Danaher to compete in the market. Furthermore, the company focuses of adoption of organic growth strategies such as manufacturing facility expansion and capacity expansion to increase its presence in the global market. For instance, in October 2023, Cytiva, a life sciences business subsidiary of Danaher, set up unit in India to get closer to biopharma customers with an investment of around USD 3 million.

Sartorius AG (Germany)

Sartorius AG offers wide range of pharmaceutical filtration products for end users such as biopharmaceutical & pharmaceutical companies, CMOs, and CROs. The company focuses on significant investment in R&D to launch products including Sartolab RF|BT Vacuum Filtration Units for pharmaceutical filtration applications. Sartorius has actively adopted strategic expansions to fulfil the demand for its products. For instance, in recent years, the company increased its geographic presence across China, the UK, South Korea, the US, Puerto Rico, and France through the establishment and expansion of manufacturing facilities and customer interaction centers to support the significant global demand for pharmaceutical filtration products. The company is expected to show high growth in the pharmaceutical filtration market during the forecast period.

For more information, Inquire Now!

Related Reports:

Laboratory Filtration Market

Hollow Fiber Filtration Market

Pharmaceutical Membrane Filtration Market

Tangential Flow Filtration Market

Sterile Filtration Market

Get access to the latest updates on Pharmaceutical Filtration Companies and Pharmaceutical Filtration Market Size

About MarketsandMarkets^™:

MarketsandMarkets^™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets^™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore^™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets^™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/

View original content:https://www.prnewswire.co.uk/news-releases/pharmaceutical-filtration-market-to-hit-usd-20-97-billion-by-2029-with-9-5-cagr--marketsandmarkets-302333600.html